120
Participants
Start Date
April 30, 2004
Primary Completion Date
October 31, 2008
Study Completion Date
Fulvestrant
500 mg intramuscular injection
Anastrazole
oral tablet
Research Site, Nottingham
Lead Sponsor
AstraZeneca
INDUSTRY